๐ˆ๐ฌ ๐ฒ๐จ๐ฎ๐ซ ๐ซ๐จ๐ฅ๐ž ๐”๐’-๐Ÿ๐จ๐œ๐ฎ๐ฌ๐ž๐? ๐€๐ซ๐ž ๐ฒ๐จ๐ฎ ๐ฅ๐จ๐จ๐ค๐ข๐ง๐  ๐Ÿ๐จ๐ซ ๐ž๐ฑ๐œ๐ข๐ญ๐ข๐ง๐  ๐ง๐ž๐ฐ ๐ฐ๐š๐ฒ๐ฌ ๐ญ๐จ ๐ ๐ž๐ง๐ž๐ซ๐š๐ญ๐ž ๐ก๐ข๐ ๐ก-๐ฏ๐š๐ฅ๐ฎ๐ž ๐‘๐–๐„?

Weโ€™re getting the word out early – Quantify is excited to attend its first US ISPOR this year in Boston, during May 7-10! We would love to connect and discuss how Nordic and other European RWD can be used to support your regulatory and commercial needs. Here is a teaser for what you can expect from Nordic data:

๐Ÿ‘‰ Full population coverage (not just population-based!) of the 27+ million residents

๐Ÿ‘‰ Patient-level linkable data spanning diagnoses, prescriptions, mortality cause and date, demographics, socioeconomics, labs, genetic information, severity, PROMs, and work loss

๐Ÿ‘‰ Decades of patient follow-up

๐Ÿ‘‰ No loss to follow-up

๐Ÿ‘‰ Real use cases supporting manufacturersโ€™ US commercial and regulatory evidence base

As a complement to RWE, or stand-alone, we also provide services in economic modelling, visualization, literature review, and meta-analysis.
Get in touch to start the conversation and let us know what info, insights, or services you might be interested in exploring:ย info@quantifyresearch.com

#RWEย #RWDย #realworldevidenceย #realworlddataย #ISPORย #QuantifyResearchย #regulatoryย #commercializationย #pharmaย #dataย #Nordicsย #Europe